4/A: Artivion CEO James P. Mackin Amends SEC Filing to Correct Stock Sale Reporting Errors

Artivion's CEO, James P. Mackin, filed an amended SEC Form 4/A to correct administrative errors in the number of shares sold to cover tax withholding obligations upon the vesting of performance stock units.

Summary

• James P. Mackin, CEO of Artivion, Inc., filed an amendment to a previous SEC Form 4 filing.
• The amendment corrects errors in the number of shares sold on February 26, 2024, to cover tax withholding obligations related to vested performance stock units.
• The original filing incorrectly reported the sale of 18,144 shares, while the corrected number is 17,868 shares.
• Similarly, another transaction was corrected from 13,168 shares to 12,968 shares.
• The amendment also adjusts the reported number of shares beneficially owned to reflect these corrections.
• The transactions were 'sell to cover' transactions, not discretionary sales.

Sentiment

Score: 6

Explanation: The sentiment is neutral. While there were errors, they were corrected transparently. The transactions were related to tax obligations, not discretionary sales.

Positives

• The CEO is transparently correcting administrative errors in SEC filings.
• The transactions were related to tax obligations, not discretionary sales, which can reassure investors.

Negatives

• The need for an amendment indicates an initial administrative oversight in reporting stock transactions.

Risks

• While the errors are corrected, repeated administrative issues could raise concerns about internal controls.

Industry Context

SEC Form 4 filings are standard practice for reporting insider transactions and are essential for maintaining market transparency. Amendments are not uncommon, but their frequency and nature are scrutinized by investors.

Comparison to Industry Standards

• Comparing Artivion's insider trading activity and reporting accuracy to similar medical device companies like Medtronic or Boston Scientific would provide a benchmark.
• Analyzing the frequency and nature of amended filings across the industry can highlight whether Artivion's situation is typical or an outlier.
• Benchmarking against companies with similar market capitalization and executive compensation structures can offer insights into best practices for stock-based compensation and tax withholding procedures.

Stakeholder Impact

• The correction of the filing ensures accurate information for shareholders.
• The 'sell to cover' transactions impact the number of shares available in the market.

Key Dates